Stem cell eye drops aim to heal stubborn corneal defects
Disease control
Terminated
This study tested an eye drop called KPI-012, made from substances released by stem cells, to see if it could heal persistent corneal epithelial defects (PCED) — wounds on the eye's surface that won't close. The trial enrolled 103 people with PCED from various causes. Participant…
Phase: PHASE2 • Sponsor: Combangio, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC